Clinical Pharmacology Lead
Pfizer
Cen (Cathy) Guo is the global clinical pharmacology lead for mutiple oncology assets in early and late-stage clinical development, including small molecules, ADC and bispecific antibody. She has experience in IND, sNDA, NDA submissions and various regulatory interactions. Her research interest includes RP2D selection, dose optimization, MIDD, and DDIs. Dr. Guo obtained her Ph.D. with a focus on clinical and preclinical DMPK from UNC-Chapel Hill.